Oriola will start distributing Takeda’s product portfolio in Finland from 1 October, expanding the long-standing Nordic partnership between the companies. The agreement reflects Takeda’s confidence in Oriola’s customer-centric way of working and ability to combine operational quality with flexibility and close collaboration.
Takeda is one of the world’s leading pharmaceutical companies and a strategic customer for Oriola. Oriola has distributed Takeda’s products in Sweden for more than 10 years, and the companies have also collaborated through Oriola’s Advisory Services.
The new distribution agreement builds on this established relationship and marks an important step in developing the partnership further in the Nordic market. It also reflects Oriola’s strategic direction as a service company built on strong partnerships, with a focus on creating value for pharmaceutical companies beyond logistics.
“This agreement supports Oriola’s strategy to be a trusted and value-adding Nordic partner for pharmaceutical companies. For us, strong distribution partnerships are built on operational quality, customer understanding and close collaboration. We are very pleased to expand our long-standing relationship with Takeda and support their needs in the Finnish market,” says Katarina Gabrielson, CEO of Oriola.
Takeda discovers and delivers life-transforming treatments in several core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Takeda’s portfolio in Finland includes pharmaceuticals used in these therapeutic areas, including specialty and high-volume products. The portfolio requires strong operational quality, expertise and continuity throughout the pharmaceutical distribution chain.
In pharmaceutical distribution, quality and reliability are the foundation. At the same time, pharmaceutical companies increasingly need partners that can help reduce local complexity, support business operations and provide services adapted to their specific needs.
“When selecting a distribution partner, it is important for us to work with a company that understands our customers’ needs and can support our operations with quality, flexibility and a collaborative approach. Oriola has shown strong engagement throughout the process, and we look forward to building our partnership in Finland,” says Takeda Finland Country Head Laura Kasslin.
For pharmaceutical companies operating in the Nordics, local market knowledge, efficient execution and a partner that understands both operational requirements and business priorities are increasingly important. The expanded partnership with Takeda demonstrates how Oriola’s Nordic platform, service expertise and customer-centric model can support pharmaceutical companies across markets and throughout the value chain.